Dermapharm Holding SE buy WatchMen
Summary
This prediction is currently active. With a performance of -7.85%, the BUY prediction for Dermapharm Holding SE by WatchMen is down slightly. This prediction currently runs until 07.03.25. The prediction end date can be changed by WatchMen at any time. WatchMen has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Dermapharm Holding SE | -1.420% | -1.420% |
iShares Core DAX® | -3.935% | -3.998% |
iShares Nasdaq 100 | -3.608% | -9.386% |
iShares Nikkei 225® | -4.513% | -8.017% |
iShares S&P 500 | -2.607% | -4.265% |
Comments by WatchMen for this prediction
In the thread Dermapharm Holding SE diskutieren